HBIO
HBIO
NASDAQ · Life Sciences Tools & Services

Harvard Bioscience Inc

$7.98
+0.02 (+0.25%)
As of Sep 28, 10:36 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +348.0% upside
Low Target $24.20
Average Target $35.75
High Target $46.73
Current Price $7.98
Current
$7.98
Target
$35.75
$24.20 $35.75 avg $46.73
Scenario Analysis
Bear Case
$24.20
203.3%
Low target
Base Case
$35.75
+348.0%
Avg target
Bull Case
$46.73
+485.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$9.40
-15.1% from high
52-Week Low
$3.75
+112.8% from low
Target vs 52W High
$35.75
+280.3% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -45.6%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -30.4%
A
Agilent Technologies Inc
Strong Buy 30 77% $64.69 -63.1%
IQV
Iqvia Holdings Inc
Strong Buy 28 82% $82.96 -69.4%
WAT
Waters Corp
Buy 31 65% $189.60 -57.2%
ILMN
Illumina Inc
Buy 28 57% $169.36 -37.7%
MTD
Mettler-Toledo International
Hold 19 53% $170.43 -89.0%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -63.7%